Position in EYPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$725,707
New position
Shares Held
56,300
first reported quarter
Ownership
0.067%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWINBEECH CAPITAL LP holds $33,258,211 across 31 Biotechnology names. EYPT ranks #20 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
65,900 | $3,829,449 | |
| 2 | TECH |
BIO-TECHNE Corp
|
56,400 | $2,947,464 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
90,006 | $2,102,540 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
221,841 | $1,998,787 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
56,100 | $1,825,494 | |
| 6 | MRNA |
Moderna, Inc.
|
34,668 | $1,761,134 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
50,900 | $1,512,239 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
76,884 | $1,503,851 |
All Filings in EYPT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $725,707 | 56,300 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||